stores. DPDPE caused a concentration-dependent inhibition of prolactin release from GH 3 MORDOR cells with an IC 50 of 4 nM. DPDPE increased inward K ϩ current recorded from GH 3 MORDOR cells but had no significant effect on K ϩ currents recorded from control GH 3 cells or GH 3 MOR cells. The receptor agonist morphine also had no effect on currents recorded from control cells but activated inward K ϩ currents recorded from GH 3 MOR and GH 3 MORDOR cells. Somatostatin activated inward currents recorded from all three cell lines. The DPDPE-sensitive K ϩ current was inwardly rectifying and was inhibited by Ba 2ϩ but not TEA. DPDPE had no effect on delayed rectifier-, Ca 2ϩ -, and voltage-activated or A-type K ϩ currents, recorded from GH 3 MORDOR cells. Ba 2ϩ attenuated the inhibition of [Ca 2ϩ ] i and prolactin release by DPDPE, whereas TEA had no effect, consistent with an involvement of K IR channels in these actions of the opioid.
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I N T R O D U C T I O N
Opioids activate , ␦, and receptors that couple through pertussis-toxin-sensitive G proteins to adenylyl cyclase and ion channels (for review, see Piros et al. 1996a) . Opioid receptors can also increase phosphatidyl inositol turnover elevating inositol 1,4,5-triphosphate (IP 3 ) levels and subsequently releasing intracellular Ca 2ϩ (Harrison et al. 1998) . In central neurons, opioid receptor activation inhibits N-and P/Q-type Ca 2ϩ channels and adenylyl cyclase, and activates inwardly rectifying K ϩ (K IR ) channels (Childers et al. 1992; North and Williams 1985; Rhim and Miller 1994; Williams et al. 1988; Wimpey and Chavkin 1991) . Any one of these actions can reduce neuronal excitability and neurotransmitter release (see Boehm and Huck 1997; Miller 1998) . Opioid receptors also couple to multiple effectors in peripheral neurons and chromaffin cells (Kleppisch et al. 1992; Moises et al. 1994; Schroeder et al. 1991; Twitchell and Rane 1994) . The activation of opioid receptors in chromaffin cells inhibits Ca 2ϩ channel activity and increases the activity of Ca 2ϩ and voltage-activated K ϩ channels (K Ca,V ) (Twitchell and Rane 1994) . This raises the question: why are so many transduction pathways required for opioid receptors to inhibit neurotransmitter and hormone release? One possibility is that the combined regulation of all of the effectors is required to effectively attenuate release. Several reports suggest that this is not the case, instead the regulation of neurotransmitter release by G-protein-coupled receptors can be explained by the involvement of specific effectors. The identity of the relevant effector varies according to the receptor and/or the preparation being studied (Boehm and Huck 1997; Capogna et al. 1993; Cherubini and North 1985; Koyama et al. 1999 ). An alternative possibility is that specific effectors must be regulated to inhibit release from cells receiving different stimuli. For example, the activation of K ϩ channels may be sufficient to inhibit spontaneous release, whereas the inhibition of adenylyl cyclase and Ca 2ϩ channels might be necessary to prevent release evoked by specific stimuli.
In this study, we used a combination of electrophysiological, fluorescence imaging ,and biochemical techniques to examine the contribution of K ϩ channels to the opioid-induced inhibition of spontaneous changes in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) and release. We required a homogeneous population of cells that both expressed opioid receptors and released measurable quantities of a neurotransmitter or hormone. Although there are opioid receptor-expressing cell lines that have been studied extensively using electrophysiological and Ca 2ϩ imaging techniques (Connor and Henderson 1996; Seward et al. 1991 ) none of these is suitable for the study of spontaneous release. We circumvented this problem by expressing cloned opioid receptors in the prolactin-secreting rat pituitary GH 3 cell line (Piros et al. 1995 (Piros et al. , 1996b and developed a sensitive enzyme-linked immunosorbent assay (ELISA) for measuring secreted prolactin levels (Charles et al. 1999; Piros et al. 1996a) . GH 3 cells have been extensively studied for several years; they have well characterized K ϩ and Ca 2ϩ channels and exhibit spontaneous oscillations of intracellular Ca 2ϩ concentration and hormone release (Barros et al. 1992; Bauer et al. 1990 Bauer et al. , 1994 Charles et al. 1999; Dubinsky and Oxford 1985; Matteson and Armstrong 1986; Oxford and Wagoner 1989) . The inhibition of K IR current stimulates the frequency of [Ca 2ϩ ] i oscillations and leads to an increase in prolactin release (Charles et al. 1999) . Conversely, inhibition of L-type Ca 2ϩ channel activity inhibits [Ca 2ϩ ] i oscillations and prolactin secretion. We stably transfected GH 3 cells with receptor cDNA to establish GH 3 cells stably expressing rat receptors (GH 3 MOR) (Piros et al. 1995) . This cell clone was subsequently stably transfected with ␦ receptor cDNA to establish GH 3 cells expressing both rat and mouse ␦ receptors (GH 3 MORDOR) (Piros et al. 1996b ). The activation of receptors expressed in either clone or ␦ receptors expressed by GH 3 MORDOR cells, leads to the inhibition of adenylyl cyclase and L-type Ca 2ϩ channel activity. Either or both of these actions may be involved in the opioid-induced reduction in prolactin release from GH 3 MORDOR cells.
The goal of this study was to use the whole cell recording technique to examine whether opioid receptors, stably expressed in GH 3 MOR and GH 3 MORDOR cells, couple to K ϩ channels. We also sought to examine the contribution of K IR channels in the ␦ receptor-mediated inhibition of spontaneous [Ca 2ϩ ] i oscillations and prolactin release.
M E T H O D S

Cell culture
GH 3 cells, obtained from the American Type Culture Collection, Rockville, MD (CCL 82.1), were maintained in Dulbecco's modified Eagle's medium supplemented with 10% (vol/vol) calf serum, penicillin (100 IU/ml), and streptomycin (100 g/ml) and incubated in a humid atmosphere of 5% CO 2 -95% air, at 37°C. GH 3 MOR or GH 3 MORDOR cells were grown under positive selection using geneticin (G418) alone or G418 plus hygromycin B, as described previously (Piros et al. 1995 (Piros et al. , 1996b . Cells were harvested once a week by treatment with a phosphate-buffered saline containing EDTA (3 mM) and reseeded at 20% of their original density, either into six-well plates for prolactin release assays, 35-mm-diameter culture dishes for electrophysiological studies, or poly-D-lysine-coated coverslips for Ca 2ϩ imaging studies. The incubation medium was changed every 2-3 days.
Electrophysiological recordings
Single GH 3 , GH 3 MOR, or GH 3 MORDOR cells were voltageclamped and voltage-activated K ϩ channel activity was recorded using a List EPC-7 patch-clamp amplifier (Cambell, CA). Cells were superfused with a solution containing (in mM) 140 NaCl, 2.8 KCl, 2 MgCl 2 , 1 CaCl 2 , 10 HEPES, 6 glucose, and 5 ϫ 10 Ϫ4 TTX (pH 7.2 with NaOH) when recording outward K ϩ currents. The recording electrode contained a solution composed of (in mM) 120 KCl, 1 EGTA, 1 MgCl 2 , 3 Mg-ATP, and 10 HEPES (pH 7.2 with KOH). Currents were activated by step-depolarizations of membrane potential from a holding potential of Ϫ80 mV for 100 ms every 10 s. Capacitance compensations were achieved using the patch-clamp amplifier. Residual artifacts and leakage currents were nulled using a P/4 subtraction.
Whole cell K IR current recordings were performed at room temperature (20 -22°C) using an extracellular solution containing (in mM): KCl 140, MgCl 2 4, CaCl 2 1, HEPES 10, glucose 7, TTX 5 ϫ 10 Ϫ4 (pH 7.2 with KOH). Recording electrodes contained a solution comprised of (in mM): KCl 140, EGTA 10, MgCl 2 2, HEPES 10, Mg-ATP 3 (pH 7.2 with KOH). Two protocols were used: Currents were evoked by a step hyperpolarization from the Ϫ40 mV holding potential to Ϫ90 mV (duration 1.5 s, frequency 0.03 Hz), no leak subtraction was employed. Alternatively, [D-Pen 2 , D-Pen 2 ]enkephalin (DPDPE), morphine, or somatostatin was bath applied to GH 3 , GH 3 MOR, and GH 3 MORDOR cells clamped at Ϫ60 mV. In some cells there was a gradual increase in the amplitude of inward current even in the absence of agonist. To compensate for this effect, a linear extrapolation was used to compare control current amplitude to the current amplitude recorded in the presence of an agonist. The currentvoltage relationship of the DPDPE activated K IR current was examined by ramping the potential from Ϫ100 to 50 mV (1-s duration). Leak subtraction was achieved by subtracting the control current recorded in response to the ramp depolarization in the absence of DPDPE.
Patch electrodes were manufactured from thin-walled borosilicate glass pipettes (World Precision Instruments, New Haven, CT) using a Flaming/Brown P-87 micropipette puller (Sutter, Novato, CA). Whole cell currents recorded using the EPC-7 amplifier were low-pass filtered with an 8-pole filter at 1 kHz and digitized (Labmaster DMA, Axon Instruments, Burlingame, CA) at a frequency of 5 kHz onto the hard drive of a personal computer. Data were analyzed using pClamp software (Axon Instruments).
Measurement of [Ca 2ϩ ] i
[Ca 2ϩ ] i was measured using a fluorescence imaging system that has previously been described in detail (Charles et al. 1991) . Briefly, cells grown on poly-D-lysine-coated glass coverslips were loaded with fura2 by incubation in 5 M fura2-AM for 40 min. Cells then were washed and maintained in normal medium for 30 min before experimentation. Coverslips were excited with a mercury lamp through 340-and 380-nm band-pass filters, and fluorescence at 510 nm was recorded through a ϫ10 or ϫ20 objective with a SIT camera to an optical memory disk recorder. Images then were digitized and subjected to background subtraction and shading correction, after which [Ca 2ϩ ] i was calculated on a pixel-by-pixel basis, as previously described, by a frame grabber and image analysis board (Data Translation). Dr. Michael Sanderson wrote data-acquisition and -analysis software. Tracings in all figures are based on fluorescence of a 4 ϫ 4 pixel area located within each cell body.
Experiments were carried out in Hanks' balanced salt solution with 10 mM HEPES buffer, pH 7.4 (HBSS/HEPES) at 20 -22°C. Agents were applied in HBSS/HEPES by perfusion of the recording chamber the base of which was a coverslip supporting the cells.
ELISA for measuring prolactin
The competitive ELISA makes use of an antibody raised in rabbit against rat prolactin. Both antisera (PRL-S-9) and standards (PRL-RP-3) were provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). GH 3 cells (0.5-0.7 million cells per well) were seeded into six-well tissue-culture plates 48 h before experimentation. Release experiments were conducted at 37°C in a humidified atmosphere of 5% CO 2 -95% air. Before each experiment, cells were washed gently with media (DMEM with 20 mM HEPES and 0.1% BSA, pH 7.4 with NaOH). After washing, aliquots of media (1 ml) were added to each well for 0.5 h at a time so that release could be monitored before, during, and after exposure to drugs. Prolactin (ng/ml/10 6 cells) released in 0.5 h in the presence of drugs was expressed as a percentage of release from the same cells during 0.5 h under control conditions. After incubation with the cells, each media aliquot was centrifuged at 1000 g at 4°C to pellet cells the supernatant was stored at Ϫ20°C or assayed directly to determine the prolactin concentration. Each well of a 96-well Nunc-Immuno Maxisorp Plate (Life Sciences, Denver, CO) was coated with prolactin by incubation of 100 l of 0.1 M NaHCO 3 , pH 9.5, containing 1 ng prolactin for 20 -24 h at 4°C. Before the assay, prolactin-coated plates were washed with assay buffer (AB) containing 0.5 M NaCl, 20 mM NaH 2 PO 4 , 0.05% Tween20, 0.5% BSA, pH to 7.4, and then incubated with AB for 0.5 h at room temperature to remove prolactin bound weakly to the plate. After further washing with AB, undiluted samples (100 l) or prolactin standards (0.02-40 ng) dissolved in 100 l media were added to the wells, followed by the addition of 50 l prolactin antibody at a dilution of 1:40,000. After incubation for 2 h at room temperature, bound antibody was detected using peroxidase-conjugated anti-rabbit antibody (Vector, Burlingame, CA) with tetramethylbenzidine (GIBCO/BRL, Gaithersburg, MD) as substrate. H 2 SO 4 (1 N) terminated the peroxidase reaction and a microplate reader (Molecular Devices) measured absorbance at 450 nm. All samples were assayed in quadruplicate from three separate determinations.
Data analysis
Data are expressed as means Ϯ SE. Statistical significance was established using Student's t-test. Comparisons between multiple data sets were made using ANOVA followed by the post hoc application of Student's t-test. Data points in the graph of DPDPE concentration versus prolactin release were fitted using the logistics equation
where P represents the prolactin concentration, P max is the maximum prolactin concentration, E max is the maximum opioid inhibited prolactin concentration (all 3 expressed as percentage of control), IC 50 is the concentration of opioid required to achieve the half-maximal effect, x is the opioid concentration, and n is the slope.
Drugs and reagents
Pertussis toxin (Sigma, MO) was added to the culture media at 200 ng/ml and cells were incubated for 24 h before performing the prolactin assay. Parallel control experiments were performed on the same batch of cells. All tissue culture reagents, including geneticin (G418) and hygromycin, were obtained from GIBCO/BRL. Nimodipine (a gift from Miles Pharmaceuticals) was diluted fresh each day from a 10 mM stock solution in ethanol. K ϩ channel inhibitors 4-AP, apamin, charybdotoxin, and iberiotoxin from RBI (Natick, MA) were put into solution on the day of the experiment. 
R E S U L T S
Opioid receptor activation inhibits spontaneous prolactin release
Previously we have determined that prolactin release from GH 3 MOR and GH 3 MORDOR cells but not GH 3 cells can be modulated by opioid ligands (Piros et al. 1996a) . In this study, we examined the cellular mechanisms by which ␦-opioid receptors inhibit prolactin release from GH 3 MORDOR cells. The ␦ receptor selective agonist DPDPE (0.1 nM to 1 M), inhibited prolactin release from GH 3 MORDOR cells with an IC 50 of 3.8 nM (Fig. 1) . The inhibition of prolactin release by DPDPE (100 nM) was attenuated by pertussis toxin pretreatment (200 ng/ml, for 24 h), demonstrating the involvement of inhibitory (Gi and/or Go) G proteins (Fig. 1) .
We previously have observed that the activation of or ␦ receptors inhibits Ca 2ϩ channel and adenylyl cyclase activity recorded from GH 3 MORDOR cells. Both of these pertussis-toxinsensitive effects could be involved in the opioid-induced inhibition of prolactin release (Piros et al. 1996b) . K ϩ channel activation is thought to be important for the inhibitory actions of opioids on neurotransmitter release from peripheral neurons (Cherubini and North 1985) . However, -opioid-induced presynaptic inhibition of GABA release from hippocampal neurons appears to be independent of K ϩ channel activity (Capogna et al. 1993) . We previously demonstrated that in GH 3 cells blockade of K IR channels, and K (Ca,V) channels increased the frequency and amplitude of [Ca 2ϩ ] i oscillations, respectively. Only the former caused enhanced prolactin release (Charles et al. 1999 ).
␦ receptor activation inhibits spontaneous [Ca 2ϩ ] i oscillations
Bath application of DPDPE (10 nM) reversibly abolished spontaneous Ca 2ϩ oscillations and decreased baseline [Ca 2ϩ ] i in the majority of GH 3 MORDOR cells (122/189 cells in 6 experiments, Fig. 2) . In some cells, it reduced the frequency of Ca 2ϩ oscillations without abolishing them altogether (42/189 cells), whereas in a smaller percentage of cells (25/189), it had no effect. DPDPE (10 -100 nM) had no effect on spontaneous Ca 2ϩ oscillations in untransfected GH 3 cells (n ϭ 3 coverslips) or GH 3 MOR cells expressing receptors alone (n ϭ 3 coverslips). The inhibitory effect of DPDPE on GH 3 MORDOR cells was blocked by pretreatment of cells with pertussis toxin (200 ng/ml, for 24 h, n ϭ 100 cells in 3 experiments, data not shown) as well as by the opioid receptor antagonist naloxone (1 M, n ϭ 90 cells in 3 experiments, data not shown). The ability of DPDPE to inhibit [Ca 2ϩ ] i oscillations was unaffected by pretreatment with 10 M thapsigargin (n ϭ 60 cells in 3 experiments, Fig. 2B (Charles et al. 1999 ). Regulation of either K ϩ or L-type Ca 2ϩ channels by ␦ receptors therefore could lead to the observed changes in [Ca 2ϩ ] i and subsequent reduction in prolactin release. We have shown previously that activation of ␦ receptors inhibits Ca 2ϩ channel activity recorded from GH 3 MORDOR cells (Piros et al. 1996b ). Here we examined whether the activation of ␦ receptors in GH 3 MORDOR cells also modulates K ϩ channel activity and, if so, whether this effect is involved in the opioid regulation of [Ca 2ϩ ] i and prolactin release.
Regulation of K ϩ channel activity in GH 3 MOR and GH 3 MORDOR cells by opioids
Depolarization of GH 3 MORDOR cells from Ϫ80 to 20 mV activates outward voltage-activated currents (Fig. 3) . Such currents were mediated by the outward flow of K ϩ , and they were abolished when CsCl replaced KCl in the electrode solution and were inhibited by K ϩ channel antagonists (e.g., Fig. 3A) . Under similar recording conditions, several studies have provided evidence for the presence of K ϩ channels that mediate delayed rectifier-, Ca 2ϩ -, and voltage-activated-and A current in GH 3 cells (Dubinsky and Oxford 1985; Oxford and Wagoner 1989; Ritchie 1987; Simasko 1991) . We have demonstrated previously that Ba 2ϩ and TEA inhibit K ϩ currents activated in GH 3 cells in response to depolarizing pulses from Ϫ80 to 20 mV. Bath application of TEA preferentially inhibited a sustained K ϩ current component that is likely to be mediated by delayed rectifying K ϩ channels (Charles et al. 1999) . By contrast, 5 mM 4-aminopyridine (4-AP) reduced a fast activating current leaving a slowly rising component (Fig.  3A) reminiscent of current through the delayed rectifier (Rudy 1988) . By subtracting the current in the presence of 4-AP from the control recording, the amplitude of the A current component recorded from GH 3 cells was observed. The 4-AP-sensitive current constituted 56 Ϯ 4% (n ϭ 4) of the peak K ϩ current activated by depolarizing from Ϫ80 to 20 mV (Fig.  3B ). The inhibition of transient K ϩ current induced by 4-AP was measured by comparing the mean current amplitudes averaged between 5 and 10 ms after depolarizing to 20 mV in the presence and absence of the drug. Apamin (100 nM) and iberiotoxin (100 nM activated K ϩ channels, caused significant parallel inhibitions of the outward K ϩ current amplitude of 2.7 Ϯ 0.6 and 21 Ϯ 6% (n ϭ 4). The effects of these agents were averaged over 10 ms at the end of each depolarizing step and were determined to be significant using the paired t-test when compared with the current in the absence of drug application (P Ͻ 0.05). The effects of the K ϩ channel inhibitors reversed during washout. Taken together with our previous observations (Charles et al. 1999 ), these data demonstrate that outward currents recorded from GH 3 cells are mediated by several classes of K ϩ channels. DPDPE (1 M) had no discernible effect on outward K ϩ currents (n ϭ 10), suggesting that activation of ␦ receptors does not effect K ϩ channels mediating delayed rectifier, K (Ca,V) , or A current recorded from GH 3 MORDOR cells (Fig. 3B ).
An inwardly rectifying K ϩ current component can also be recorded from GH 3 cells under appropriate conditions (Bauer et al. 1990; Charles et al. 1999) . Hyperpolarizing GH 3 cells from Ϫ40 to Ϫ90 mV with equal K ϩ concentrations on either side of the cell membrane reveals inward currents. Such currents are inhibited by Cs ϩ (1 mM) and Ba 2ϩ (1 mM) but are insensitive to 1 mM TEA (Charles et al. 1999) . The bath application of DPDPE (1 M) increased the amplitude of currents (by 31 Ϯ 4%, n ϭ 6) observed by hyperpolarizing GH 3 MORDOR cells from Ϫ40 to Ϫ90 mV, suggesting that opioid receptors couple to K IR channels (Fig.  4A) . This suggestion is supported by the demonstration that currents recorded in the presence of DPDPE are inhibited by bath application of 1 mM Ba 2ϩ (Fig. 4B) . To test whether the DPDPE-induced current was truly inwardly rectifying, we examined the relationship between current amplitude and holding potential using voltage ramps from Ϫ100 to 50 mV (Fig. 4C) . Currents generated by the voltage ramp under control conditions were subtracted from those observed in the presence of DPDPE. In an attempt to restrict the actions of the opioid to K ϩ channel activation, we performed experiments in the presence of the dihydropyridine nimodipine (100 M) at a sufficient concentration to abolish Ca 2ϩ channel activity in GH 3 cells (Piros et al. 1995) . Subtraction of ramp currents recorded in the presence of nimodipine alone from those recorded with both nimodipine and DP-DPE (100 nM) revealed inwardly rectifying currents (n ϭ 5) that reversed in sign at the K ϩ equilibrium potential of 0 mV (Fig. 4C) .
To confirm that DPDPE was selectively activating ␦ receptors in GH 3 MORDOR cells, we tested the sensitivity of control GH 3 cells and GH 3 MOR cells expressing receptors alone. Cells were held at Ϫ60 mV while DPDPE, somatostatin (an agonist of somatostatin receptors native to GH 3 cells), or morphine (a receptor agonist) were bath applied (Fig. 5) . Clearly discernible inward currents (87 Ϯ 11 pA, n ϭ 9) recorded from control GH 3 cells developed in the presence of somatostatin (1 M). No increase in the amplitudes of inward currents were observed on application of morphine (1 M) or DPDPE (100 nM) to control GH 3 cells (n ϭ 5 and 8, respectively). By contrast, DPDPE (100 nM) activated robust currents (168 Ϯ 23 pA, n ϭ 16) recorded from GH 3 MORDOR cells (Fig. 5) but had no significant effect on currents recorded from GH 3 MOR cells (n ϭ 11, Fig. 5 ). Both somatostatin (1 M) and morphine (1 M) activated currents recorded from GH 3 MOR cells (169 Ϯ 25 pA, n ϭ 13 and 197 Ϯ 46 pA, n ϭ 12, respectively). The more selective receptor agonist DAMGO (1 M) also activated inward currents recorded from GH 3 MOR and GH 3 MORDOR cells (data not shown).
FIG. 4. DPDPE activates Ba
2ϩ -sensitive inward K ϩ channel activity. A: DPDPE (1 M) increased the amplitude of inward K ϩ currents recorded, while hyperpolarizing cells from Ϫ40 to Ϫ90 mV. In these experiments, to increase the current amplitude, intracellular and extracellular K ϩ concentrations were approximately equal (see METHODS). B: bar graph of the average DPDPE (1 M)-evoked potentiation of inward K ϩ current under control conditions and in the presence of Ba 2ϩ (1 mM). Ba 2ϩ caused a significant inhibition of the increase in K ϩ current by DPDPE (P Ͻ 0.05). Error bars represent SE. Control data were recorded from 6 cells; coapplication experiments were performed on 4 cells. The effect of DPDPE was determined by averaging control and enhanced current amplitudes over the last 200 ms before the end of each hyperpolarizing pulse. C: graph illustrating the relationship between the DP-DPE (100 nM)-evoked current amplitude and voltage. The curve represents the result of subtracting currents evoked by ramps in the presence of nimodipine (100 M) alone from currents activated in the presence of DPDPE (100 nM) and nimodipine. GH 3 MORDOR cells were depolarized from Ϫ100 to 50 mV in 1 s. The trace is an average of ramp-generated currents recorded from 5 cells. Data are expressed as average current relative to cell capacitance, providing a measure of current density (pA/pF).
DPDPE inhibits [Ca 2ϩ ] i oscillations and prolactin release by activating K IR channels
We exploited the selective K ϩ channel blocking actions of extracellular Ba 2ϩ and TEA to examine whether DPDPE induces inhibition of [Ca 2ϩ ] i oscillations and prolactin release through activation of K IR current. The inhibition of [Ca 2ϩ ] i oscillations by DPDPE (10 -100 nM) was attenuated by the preapplication of 1 mM Ba 2ϩ (n ϭ 60 cells in 3 experiments, Fig. 6A ) but was unaffected by 1 mM TEA (n ϭ 75 cells in 3 experiments, Fig. 6B ). Likewise, the DPDPE (1 M)-evoked inhibition of prolactin release was inhibited by coapplication with Ba 2ϩ (1 mM) or Cs ϩ (1 mM), another ion capable of inhibiting K IR channel activity (Fig. 6C) . The increase in prolactin release in the presence of Ba 2ϩ and DPDPE was not significantly different from that observed when Ba 2ϩ was applied alone to GH 3 cells (Charles et al. 1999) , confirming that DPDPE has no discernible effect on prolactin release when K IR channels are inhibited (Fig. 6C ). There was also no significant difference between the change in prolactin release when Cs ϩ (1 mM) was applied alone to GH 3 cells (Charles et al. 1999) or coapplied with DPDPE (1 M; Fig. 6C ). TEA had no significant effect on the inhibition of prolactin release by DPDPE. DPDPE (1 M) inhibited prolactin levels by 29 Ϯ 7% (n ϭ 4) and 39 Ϯ 4% (n ϭ 11) in the presence and absence of TEA (1 mM). TEA (1 mM) applied alone to GH 3 cells had no effect on prolactin release (Charles et al. 1999) .
Taken together, these data suggest that activation of K IR channels by DPDPE reduces spontaneous [Ca 2ϩ ] i oscillations and prolactin release.
D I S C U S S I O N
We previously established excitable, prolactin-secreting anterior pituitary-derived GH 3 cell lines stably expressing either receptors alone (GH 3 MOR cells) or and ␦ receptors (GH 3 MORDOR cells) together (Piros et al. 1995 (Piros et al. , 1996b Charles et al. (1999) are shown here for the purpose of comparison ( †).
GH 3 cells were chosen as the system for expression of cloned opioid receptors as they contain a variety of wellcharacterized G proteins and several effectors regulated by native somatostatin and muscarinic receptors (Hescheler and Schultz 1993) . Unlike unexcitable cell lines more commonly used to study cloned opioid receptors, GH 3 cells also express a range of voltage-activated ion channels as well as adenylyl cyclase. Furthermore these cells exhibit spontaneous oscillations of [Ca 2ϩ ] i and prolactin release. Therefore opioid receptor properties, from ligand binding to regulation of hormone release, can be studied using this single clonal cell system (Piros et al. 1996a) .
The activation of either or ␦ receptors expressed in GH 3 cells leads to the inhibition of the activities of adenylyl cyclase and dihydropyridine-sensitive Ca 2ϩ channels (Piros et al. 1995 (Piros et al. , 1996b . Reductions in the intracellular concentration of cAMP and Ca 2ϩ entry may contribute to the opioid-induced reduction in prolactin release. Indeed the inhibition of Ca 2ϩ channel activity by nimodipine caused both a reduction in spontaneous [Ca 2ϩ ] i oscillations and prolactin release, suggesting that the entry of Ca 2ϩ through L-type channels plays an important part in these processes in GH 3 cells (Charles et al. 1999) .
In the present study DPDPE caused a marked reduction in spontaneous [Ca 2ϩ ] i oscillations in GH 3 MORDOR but not GH 3 MOR or control GH 3 cells, demonstrating that this effect required ␦ receptor activation. We examined the possibility that ␦ receptors could be regulating [Ca 2ϩ ] i through modulation of IP 3 -sensitive intracellular Ca 2ϩ stores, a phenomenon that has been observed in NG108 -15 cells (Jin et al. 1994 ). This pathway does not appear to be important in the actions of ␦ receptors in GH 3 MORDOR cells because the DPDPE-induced reduction in [Ca 2ϩ ] i oscillations persisted after application of thapsigargin. The application of thapsigargin had little effect on spontaneous Ca 2ϩ oscillations, suggesting that IP 3 -sensitive intracellular Ca 2ϩ stores play only a minor role in the control of this process in GH 3 cells (Charles et al. 1999) .
The activation of ␦ receptors increased the amplitude of a Ba 2ϩ -sensitive inward rectifying K ϩ current recorded from GH 3 MORDOR cells. Consistent with the idea that this effect is mediated specifically by ␦ receptors, DPDPE did not activate currents in GH 3 or GH 3 MOR cells. GH 3 cells express endogenous somatostatin receptors that are known to couple to K IR channels. Somatostatin activated inward currents in all three cell lines, whereas the receptor agonists morphine and DAMGO activated resolvable currents only in GH 3 MOR and GH 3 MORDOR cells. This action of the opioids appears to be specific to K IR channels as DPDPE did not regulate outward K ϩ currents mediated by TEA-, 4-AP-, apamin-, charybdotoxin-, or iberiotoxin-sensitive channels. TEA, Ba 2ϩ , and Cs ϩ have been used previously to examine the roles of K (Ca,V) and K IR channels in spontaneous [Ca 2ϩ ] i oscillations and prolactin release from GH 3 cells (Charles et al. 1999) . TEA (1 mM) selectively inhibits outward K ϩ current, Cs ϩ (1 mM) selectively inhibits inward currents, whereas Ba 2ϩ (1 mM) inhibits both K ϩ current components. The application of Ba 2ϩ but not TEA increased the frequency of Ca 2ϩ oscillations, an action that is accompanied by an increase in prolactin release (Charles et al. 1999) . In the present study, we demonstrated that, consistent with an effect primarily involving K IR , the DPDPEmediated inhibitions of Ca 2ϩ signaling and prolactin release were attenuated by Ba 2ϩ but not by TEA.
Opioid receptors are known to couple to K IR channels in a variety of neurons (Grudt and Williams 1993; North and Williams 1985; Wimpey and Chavkin 1991) , an effect that can be mimicked by expressing opioid receptors with G-protein-coupled inwardly rectifying K ϩ channels (GIRK) in Xenopus oocytes (Chen and Yu 1994; Henry et al. 1995; Ikeda et al. 1995; Ma et al. 1995) . This action appears to be mediated by activation of inhibitory G proteins liberating ␤␥ subunits that bind directly to an amino acid motif found on GIRK channels and several other effectors regulated by G-protein-coupled receptors (Ford et al. 1998 ). The molecular identity of the G-protein-regulated K IR channel in GH 3 cells remains unknown (Falk et al. 1995) . Early reports implicate G-protein ␣ subunits in the activation of K IR channels in GH 3 cells (Codina et al. 1987; Yatani et al. 1988) . Whether G-protein ␣ subunits are involved in the regulation of K IR channels by recombinant opioid receptors expressed in GH 3 cells remains to be examined.
In summary, taken together the results of this study indicate that on activation cloned opioid receptors stimulate K IR channels native to GH 3 cells preventing depolarization and the influx of Ca 2ϩ through voltage-activated Ca 2ϩ channels thus reducing spontaneous Ca 2ϩ oscillations and prolactin release. Our findings with this model system may be more widely applicable to other neuronal and endocrine cells at times of tonic neurotransmitter or hormone release when opioid-receptor-mediated activation of K IR channels can prevent spontaneous depolarization. We speculate that the other actions mediated by opioid receptors in GH 3 MOR and GH 3 MORDOR cells, inhibition of L-type Ca 2ϩ channel activity and adenylyl cyclase (Piros et al. 1995 (Piros et al. , 1996b , may play a role when hormone release is stimulated by exogenous signals causing depolarization and increased intracellular cAMP levels, respectively. Multiple effector mechanisms may enable opioid receptor agonists to inhibit either basal or evoked Ca 2ϩ signaling and hormone release.
